Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

pany Chief Manufacturing and Labor Affairs Officer Gary Johnson, 'China Rx: Exposing the Risks of America's Dependence on China for Medicine' author Rosemary Gibson, Economic Policy Institute Trade and Manufacturing Policy Research Director and Senior Economist Robert Scott, and Hudson Institute Senior Fellow T

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

any Chief Manufacturing and Labor Affairs Officer Gary Johnson, 'China Rx: Exposing the Risks of America's Dependence on China for Medicine' author Rosemary Gibson, Economic Policy Institute Trade and Manufacturing Policy Research Director and Senior Economist Robert Scott, and Hudson Institute Senior Fellow To

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

any Chief Manufacturing and Labor Affairs Officer Gary Johnson, 'China Rx: Exposing the Risks of America's Dependence on China for Medicine' author Rosemary Gibson, Economic Policy Institute Trade and Manufacturing Policy Research Director and Senior Economist Robert Scott, and Hudson Institute Senior Fellow T

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

any Chief Manufacturing and Labor Affairs Officer Gary Johnson, 'China Rx: Exposing the Risks of America's Dependence on China for Medicine' author Rosemary Gibson, Economic Policy Institute Trade and Manufacturing Policy Research Director and Senior Economist Robert Scott, and Hudson Institute Senior Fellow T